Welcome to our dedicated page for Oscar Health news (Ticker: OSCR), a resource for investors and traders seeking the latest updates and insights on Oscar Health stock.
Oscar Health, Inc. reports news on its healthcare technology business, which uses a full-stack platform to offer Individual & Family health plans, ICHRA solutions, +Oscar technology services and the Lucie Health Marketplace. Company updates commonly cover quarterly financial results, medical loss ratio and expense metrics, guidance, membership trends and product expansion in the individual health insurance market.
Oscar Health announcements also include marketplace and plan launches, broker and employer-facing healthcare shopping tools, technology features, capital-structure activity and board governance changes. The company’s recurring news themes connect its insurance products, member experience and healthcare technology services to developments in ACA exchange markets and consumer-directed coverage.
Oscar Health, Inc. (NYSE: OSCR) has renewed its Pharmacy Benefit Manager agreement with CVS Caremark, aiming to enhance cost efficiency for its members. The new agreement, effective from 2023 and extending through 2026, focuses on continued access to CVS Caremark's pharmacy network while allowing Oscar to shape formulary design. Scott Blackley, Chief Transformation Officer, highlighted that CVS Caremark's offer aligns with Oscar's strategic goals of lower costs and enhanced service. This partnership, ongoing since 2012, aims to optimize Oscar's tech-enabled business model and improve member healthcare experience.
Oscar Health, Inc. (NYSE: OSCR) announced that Co-Founder & CEO Mario Schlosser and CFO Sid Sankaran will present at the Cowen 43rd Annual Health Care Conference on March 6, 2023 at 10:30 AM ET. The presentation will be accessible via a virtual webcast, with the link available in the announcement. Following the event, the archived call will be accessible on Oscar's investor relations website. Oscar Health is known for its technology-driven health insurance platform and commitment to enhancing member experiences.
Oscar Health, Inc. (NYSE: OSCR) announced on February 6, 2023, the approval of inducement restricted stock unit awards for 12 new non-executive employees, totaling 832,126 Class A shares. These awards are designed to attract talent under the 2022 Employment Inducement Award Plan and typically vest over one to three years, contingent on continued employment. Oscar Health, founded in 2012, focuses on providing health insurance through a technology-driven platform. The company aims to enhance healthcare accessibility and affordability, having gained over one million members as of December 31, 2022.
Oscar Health, Inc. (NYSE: OSCR) reported a strong financial performance for 2022, with Direct and Assumed Policy Premiums of $6.8 billion, a 99% increase YoY, and earnings of $3.9 billion, a 111% surge. The company improved its Medical Loss Ratio to 85.3% (360 bps improvement) and its Combined Ratio to 105.8% (490 bps improvement). However, it still faced a net loss of $610 million, up $38 million YoY. Looking forward, Oscar anticipates Direct and Assumed Policy Premiums between $6.4 billion and $6.6 billion and projects a Combined Ratio at or below 100% for 2023.
Oscar Health, Inc. (NYSE: OSCR) will release its fourth quarter 2022 and full year 2022 financial results on February 9, 2023, after market close. A conference call will be held at 5:00 PM (ET) to discuss these results. The call can be accessed via a live call or a webcast link, both of which will be available on Oscar's investor relations website following the results announcement. Oscar is known for its technology-driven approach to health insurance and aims to provide affordable health care to its members.
Oscar Health, Inc. (NYSE: OSCR) announced that Co-Founder & CEO Mario Schlosser will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 5:15 PM PT (8:15 PM ET) in San Francisco, CA. Interested parties can listen to a webcast of the presentation on Oscar's investor relations website. Oscar, established in 2012, focuses on making healthcare accessible and affordable, serving over one million members as of September 30, 2022, through a technology-driven approach and a mission to improve member experiences.
Oscar Health, Inc. (NYSE: OSCR) announced it will stop accepting new members in Florida starting December 13 at 12:00 a.m. EST, due to strong Open Enrollment performance. Current members can renew their plans without disruption. This decision follows Oscar's proactive engagement with regulators to manage membership growth and ensure financial stability, as they aim to maintain their target membership of approximately 1 million. Oscar remains committed to the Florida market and will continue to provide coverage throughout 2023 and beyond.
Summary not available.
Oscar Health, Inc. (NYSE: OSCR) has appointed Bill Gassen and Laura Lang to its Board of Directors effective December 7, 2022. Gassen, currently CEO of Sanford Health, brings extensive healthcare leadership experience, while Lang, former CEO of Time Inc., adds valuable expertise in digital business transformation. Oscar’s CEO, Mario Schlosser, emphasizes that their diverse backgrounds will enhance the board’s capabilities as the company strives to innovate and improve accessibility in healthcare. Jeffery Boyd, the Chairman, believes their leadership will be crucial for Oscar’s growth.
Oscar Health (NYSE: OSCR) has announced an expansion of its provider network in Nashville, TN, adding Vanderbilt University Medical Center (VUMC) and its affiliates to its in-network options. This initiative aims to enhance access to quality healthcare for members during the ongoing Open Enrollment period, with coverage effective from January 1, 2023. Oscar members will benefit from VUMC's extensive services and Oscar's digital health tools, including 24/7 access to virtual urgent care at no cost and Tier 1 prescriptions also at no cost.